Primaquine phosphate

Primaquine phosphate
PRIMAQUINE PHOSPHATE^® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]

Overview

Primaquine (or primaquine phosphate) is a medication used in the treatment of malaria and Pneumocystis pneumonia. It is a member of the 8-aminoquinoline group of drugs that includes tafenoquine and pamaquine. Primaquine was first synthesised by Robert Elderfield of Columbia University in the 1940's.^[1]

US Brand Names

FDA Package Insert

Mechanism of Action

References

↑ Edgcomb JH, Arnold J, Young EH; et al. (1950). "Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report". Journal National Malaria Society. 9 (4): 285&ndash, 92. PMID 14804087.

[1] Edgcomb JH, Arnold J, Young EH; et al. (1950). "Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report". Journal National Malaria Society. 9 (4): 285&ndash, 92. PMID 14804087.

[1]